Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of Response to Montelukast in Pediatric Asthma
NCT00721240Phase 4Completed
- Sponsor
- Marien-Hospital Wesel
- Start
- Feb 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of montelukast in asthma, sponsored by Marien-Hospital Wesel. Primary endpoint: Bronchospasmolytic effect (FEV1 increased by at least 5%). Started Feb 2006; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00721240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00721240.